Compare Inovio Pharmaceuticals Inc (INO) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Upwork Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Upwork Inc trades at $9.17 (market cap $1.15B). The key difference: Upwork Inc is far larger — about 12.9× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| INO | UPWK | |
|---|---|---|
Market Cap | $89.27M | $1.15B |
Sector | Health | Industrials |
52-Week High | $2.87 | $22.11 |
52-Week Low | $1.05 | $7.84 |
Enterprise Value | $60.28M | $952.17M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $1.10, down 1.79% recently, with a bearish technical signal from moving averages. The company shows minimal revenue of $65,340 in 2025 and a net loss of $84.95 million, resulting in negative profitability margins. Recent news highlights an ongoing FDA review for INO-3107 with a PDUFA date of October 30, 2026, while shareholder litigation investigations emerge. Cash flow remains negative, though operating expenses have declined.
The investment case hinges on the binary FDA decision for INO-3107, offering potential upside if approved, but carries high risk due to persistent losses, negative cash flow, and legal scrutiny. Analyst consensus is moderately bullish with 53% buy ratings, but fundamental weaknesses and technical bearishness suggest cautious positioning is warranted.
UPWK trades at $9.19, up 1.43% today, with a bullish technical signal from moving averages. The company reported $788M revenue in 2025 with strong profitability margins (net income margin 13.81%) and attractive valuation ratios (P/E 11.52, P/S 1.64). Recent news highlights AI integration initiatives and Q2 2026 earnings anticipation, though legal investigations pose sentiment headwinds.
The outlook is cautiously optimistic with a $10.67 analyst price target suggesting 16% upside. Key opportunities include sustained revenue growth and AI-powered marketplace expansion, while risks involve earnings misses, legal overhangs, and competitive pressures in the gig economy space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
